These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9788635)

  • 1. Information processing in schizophrenia and bipolar disorder: a discriminant analysis.
    Tam WC; Sewell KW; Deng HC
    J Nerv Ment Dis; 1998 Oct; 186(10):597-603. PubMed ID: 9788635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neurocognition between drug-free patients with schizophrenia and bipolar disorder.
    Tam WC; Liu Z
    J Nerv Ment Dis; 2004 Jul; 192(7):464-70. PubMed ID: 15232316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder.
    Szoke A; Meary A; Trandafir A; Bellivier F; Roy I; Schurhoff F; Leboyer M
    Eur Psychiatry; 2008 Jan; 23(1):20-5. PubMed ID: 18083013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye movements and psychopathology in schizophrenia and bipolar disorder.
    Tien AY; Ross DE; Pearlson G; Strauss ME
    J Nerv Ment Dis; 1996 Jun; 184(6):331-8. PubMed ID: 8642381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological functioning in bipolar disorder and schizophrenia.
    Schretlen DJ; Cascella NG; Meyer SM; Kingery LR; Testa SM; Munro CA; Pulver AE; Rivkin P; Rao VA; Diaz-Asper CM; Dickerson FB; Yolken RH; Pearlson GD
    Biol Psychiatry; 2007 Jul; 62(2):179-86. PubMed ID: 17161829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Chen CK; Lee CY; Lee Y; Hung CF; Huang YC; Lee SY; Huang MC; Chong MY; Chen YC; Wang LJ
    Psychiatry Res; 2018 Aug; 266():79-84. PubMed ID: 29852325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction time measures of sustained attention differentiate bipolar disorder from schizophrenia.
    Fleck DE; Sax KW; Strakowski SM
    Schizophr Res; 2001 Dec; 52(3):251-9. PubMed ID: 11705718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Backward masking in schizophrenia and mania. I. Specifying a mechanism.
    Green MF; Nuechterlein KH; Mintz J
    Arch Gen Psychiatry; 1994 Dec; 51(12):939-44. PubMed ID: 7979881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
    Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
    Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.
    Depp CA; Moore DJ; Sitzer D; Palmer BW; Eyler LT; Roesch S; Lebowitz BD; Jeste DV
    J Affect Disord; 2007 Aug; 101(1-3):201-9. PubMed ID: 17224185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).
    Yatham LN; Torres IJ; Malhi GS; Frangou S; Glahn DC; Bearden CE; Burdick KE; Martínez-Arán A; Dittmann S; Goldberg JF; Ozerdem A; Aydemir O; Chengappa KN
    Bipolar Disord; 2010 Jun; 12(4):351-63. PubMed ID: 20636632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers.
    Liu SK; Chiu CH; Chang CJ; Hwang TJ; Hwu HG; Chen WJ
    Am J Psychiatry; 2002 Jun; 159(6):975-82. PubMed ID: 12042186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.